The landscape of different molecular modules in an immune microenvironment during tuberculosis infection

Tuberculosis is a chronic inflammatory disease caused by Mycobacterium tuberculosis. When tuberculosis invades the human body, innate immunity is the first line of defense. However, how the innate immune microenvironment responds remains unclear. In this research, we studied the function of each type of cell and explained the principle of an immune microenvironment. Based on the differences in the innate immune microenvironment, we modularized the analysis of the response of five immune cells and two structural cells. The results showed that in the innate immune stress response, the genes CXCL3, PTGS2 and TNFAIP6 regulated by the nuclear factor kappa B(NK-KB) pathway played a crucial role in fighting against tuberculosis. Based on the active pathway algorithm, each immune cell showed metabolic heterogeneity. Besides, after tuberculosis infection, structural cells showed a chemotactic immunity effect based on the co-expression immunoregulatory module.

[1]  J. Matías‐Guiu,et al.  Variants of genes encoding TNF receptors and ligands and proteins regulating TNF activation in familial multiple sclerosis , 2020, CNS neuroscience & therapeutics.

[2]  Boning Zeng,et al.  Commentary: Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis , 2020, Frontiers in Immunology.

[3]  Huan Xiong,et al.  PE_PGRS31-S100A9 Interaction Promotes Mycobacterial Survival in Macrophages Through the Regulation of NF-κB-TNF-α Signaling and Arachidonic Acid Metabolism , 2020, Frontiers in Microbiology.

[4]  J. Pieters,et al.  Mycobacterium tuberculosis and the macrophage: maintaining a balance. , 2008, Cell host & microbe.

[5]  F. Liu,et al.  Innate scavenger receptor-A regulates adaptive T helper cell responses to pathogen infection , 2017, Nature Communications.

[6]  Edwin Wang,et al.  Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk , 2019, JAMA network open.

[7]  Y. Av‐Gay,et al.  Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis , 2015, Immunological reviews.

[8]  J. Rengarajan,et al.  Immunology of Mycobacterium tuberculosis Infections , 2019, Microbiology spectrum.

[9]  J. Ernst,et al.  Tuberculosis pathogenesis and immunity. , 2012, Annual review of pathology.

[10]  Yuan Zhou,et al.  Identification and analysis of the human sex-biased genes , 2016, Briefings Bioinform..

[11]  Jason W Locasale,et al.  Metabolic landscape of the tumor microenvironment at single cell resolution , 2019, Nature Communications.

[12]  Michael Y. Gerner,et al.  Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination. , 2018, Cell host & microbe.

[13]  G. Maartens,et al.  Tuberculosis , 1936, The Lancet.

[14]  B. Zhong,et al.  Syk Regulation of Phosphoinositide 3-Kinase-Dependent NK Cell Function1 , 2002, The Journal of Immunology.

[15]  M. Wood,et al.  Maternal HIV status skews transcriptomic response in infant cord blood monocytes exposed to BCG. , 2020, AIDS.

[16]  K. Moore,et al.  Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism , 2016, Nature Immunology.

[17]  Marco Masseroli,et al.  The road towards data integration in human genomics: players, steps and interactions , 2020, Briefings Bioinform..

[18]  Amit Kumar Srivastava,et al.  NOS2A promoter (CCTTT)n association with TB lacks independent functional correlation amongst Indians. , 2014, Tuberculosis.

[19]  M. Netea,et al.  Mycobacterial growth inhibition is associated with trained innate immunity , 2018, The Journal of clinical investigation.

[20]  G. Sirugo,et al.  Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. , 2008, American journal of respiratory and critical care medicine.

[21]  Dietrich Rebholz-Schuhmann,et al.  Deep learning-based clustering approaches for bioinformatics , 2020, Briefings Bioinform..

[22]  Aditi Gupta,et al.  Mycobacterium tuberculosis progresses through two phases of latent infection in humans , 2020, Nature Communications.

[23]  M. Netea,et al.  Trained innate immunity and resistance to Mycobacterium tuberculosis infection. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.